No abstract available
MeSH terms
-
Androgen Antagonists / therapeutic use*
-
Androstenes / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biomarkers, Tumor
-
Drug Resistance, Neoplasm / genetics
-
Humans
-
Male
-
Mutation
-
Neoplasm Metastasis / diagnosis
-
Neoplasm Metastasis / drug therapy
-
Prostatic Neoplasms / drug therapy*
-
Prostatic Neoplasms / genetics
-
Prostatic Neoplasms / pathology*
Substances
-
Androgen Antagonists
-
Androstenes
-
Biomarkers, Tumor
-
abiraterone